Press Releases for the Psychedelics Industry

Psychedelics News

Press Releases

Industry, Press Releases

25 Jul 2022

Mindbio Research Partners Receive $1.4 M Grant for Microdosing Trial

Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1....

By Microdose NewsDesk

Press Releases

23 Jun 2022

Ceruvia Lifesciences Submits Phase 1 Trial Application With the FDA

Based on a positive pre-IND meeting with the U....

By Microdose NewsDesk

Press Releases

17 Jun 2022

Psylo To Collaborate with NIDA to Evaluate Psylo’s Lead Candidate Drug

Psylo and NIDA will collaborate on the preclinical development and testing of Psylo’s novel compounds...

By Microdose

Industry, Press Releases

13 Jun 2022

Launch of the Psychedelic Access and Research European Alliance – PAREA

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

26 Apr 2022

Albert Labs Announces the Addition of Renowned Scientists

Professor Robert Britton and Dr Ricardo Jorge Dinis-Oliveira bring drug development and pharmacology/toxicological expertise to Albert Labs's board....

By Microdose

Press Releases

31 Mar 2022

Albert Labs’ Files U.S. Patent Application for Production of Psilocybe Mycelia and other Fungi Species

Albert Labs’ culturing process can significantly increase the production volumes of psilocybin medicine...

By Microdose

Press Releases

17 Feb 2022

Enveric Biosciences and University of Calgary Collaborate on a Groundbreaking Clinical Trial for EVM-101 in Cancer Related Distress

Clinical trial aim is to include the identification and characterization of the Cancer Related Distress symptoms most responsive to psychedelic-associated therapy...

By Microdose

Press Releases

10 Feb 2022

Mindstate Design Labs Launches to Create the Next Generation of Psychedelic Therapeutics

Mindstate Design Labs Launches to Create the Next Generation of Psychedelic Therapeutics Emerging from Y Combinator’s S21 cohort with $11....

By Microdose

Press Releases

4 Feb 2022

Special Newswire Offer for Presenting Companies

InvestorWire is providing a special offer to expand the distribution of any announcement....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result